Metraipolis › archive › dc_897a1fa73008
Yttrium-90 radioembolization for neuroendocrine liver metastases: baseline vascularity predicts cytoreduction efficacy — Europe PMC PMID:42447129
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42447129
- DOI
- 10.1371/journal.pone.0352018
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T07:21:44.311Z
- SHA-256 of the archived text
fc12fd90a44d2978e83c77b59b0dca3d257d0859001536d0cce2cf55b83d9118- Stable URL of this page
https://metraipolis.com/documento/dc_897a1fa73008
How to cite
Yttrium-90 radioembolization for neuroendocrine liver metastases: baseline vascularity predicts cytoreduction efficacy — Europe PMC PMID:42447129 — Europe PMC (en), https://europepmc.org/article/MED/42447129 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_897a1fa73008 (Metraipolis archive dc_897a1fa73008, sha256 fc12fd90a44d2978e83c77b59b0dca3d257d0859001536d0cce2cf55b83d9118)
BibTeX
@misc{dc897a1fa73008,
title = {Yttrium-90 radioembolization for neuroendocrine liver metastases: baseline vascularity predicts cytoreduction efficacy — Europe PMC PMID:42447129},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42447129},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_897a1fa73008; sha256 fc12fd90a44d2978e83c77b59b0dca3d257d0859001536d0cce2cf55b83d9118},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42447129. Agents can read the archived copy with the MCP tool read_document.